We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS SUMMARY: Ocado Chair Rose Sells GBP1.7 Million Worth

Thu, 27th Feb 2020 17:00

(Alliance News) - The follow is a round-up of share dealings by UK company directors and managers announced on Thursday and not separately reported by Alliance News:

----------

Ocado Group PLC - Chair Stuart Rose sells 150,000 shares at GBP11.2463, worth GBP1.7 million, on Wednesday.

----------

Vodafone Group PLC - Non-Executive Director David Thodey buys 203,653 shares at GBP1.51, worth GBP307,516, on Tuesday.

----------

Saga PLC - Chief Executive Officer Euan Sutherland buys 253,984 shares at GBP0.3937, worth GBP99,994. Chief Financial Officer James Quin buys 108,258 shares at GBP0.3675, worth GBP39,785. Both purchased made on Wednesday.

----------

Workspace Group PLC - Chair Daniel Kitchen sells 10,000 shares at 1,220.23 pence, worth GBP122,023, on Wednesday.

----------

Naked Wines PLC - Chair John Walden buys 26,300 shares at GBP2.20, worth GBP57,860, on Tuesday. It is Walden's only holding.

----------

Redde Northgate PLC - Non-Executive Chair Avril Palmer-Baunack buys 19,766 shares at 252.95 pence, worth GBP49,998, on Thursday. Now holds 69,179 shares.

----------

Fidelity China Special Situations PLC - Non-Executive Director Mike Balfour buys 20,000 shares at GBP2.2639, worth GBP45,278, on Thursday. Now holds 65,000 shares.

----------

AstraZeneca PLC - Non-Executive Director Tony Mok buys 1,000 American Depositary Shares at USD48.00, worth USD48,000, on Wednesday. Two ADSs equal one AstraZeneca ordinary share.

----------

Pets At Home Group PLC - Chief People & Culture Officer Louise Stonier sells 4,520 shares at GBP3.1409, and spouse Paul Stonier sells same number at GBP3.14, both on Tuesday. Together the sales are worth GBP28,390.

----------

Nippon Active Value Fund PLC - Director Alicia Ogawa buys 25,000 shares at 100 pence, worth GBP25,000, on Friday last week.

----------

Hunting PLC - Non-Executive Director Carol Chesney buys 4,000 shares at 304.08 pence, worth GBP12,163. Now holds 9,000 shares.

----------

Primorus Investments PLC - Non-Executive Chair Jeremy Taylor-Firth buys 90,000 shares on Tuesday and 200,000 shares on Wednesday, all at 3 pence, worth GBP2,700. Now holds 915,000 shares, 0.7% of total.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more
19 Feb 2024 08:03

AstraZeneca's Tagrisso gains FDA approval

(Sharecast News) - Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.

Read more
19 Feb 2024 07:49

LONDON BRIEFING: MoneySupermarket credits Insurance for growth in 2023

(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.